84 results
Page 2 of 5
F-3
brtncw
12 Jan 24
Shelf registration (foreign)
4:15pm
6-K
EX-99.1
1urdletr7k hh
3 Jan 24
PainReform Reports Successful Head-to-Head Comparison
8:36am
6-K
EX-99.1
g5cpus4v
26 Dec 23
PainReform Announces Exercise of Warrants for Approximately $1.3 Million in Gross
6:08pm
6-K
EX-99.3
q2q88nmh
15 Nov 23
Condensed Financial Statements
4:09pm
6-K
EX-99.2
zsbywjjx0ltvwoy
15 Nov 23
Condensed Financial Statements
4:09pm
6-K
EX-99.1
v6wdx4t il4dnf
11 Sep 23
Trial completion and results expected in mid-2024
8:41am
424B3
wdg1kft71
5 Sep 23
Prospectus supplement
4:16pm
F-1
p7wlqt2z6la 0wxrnve6
25 Aug 23
Registration statement (foreign)
4:15pm
6-K
EX-99.3
7enpou4t
10 Aug 23
Current report (foreign)
4:18pm
6-K
EX-99.2
06l9g1r6 74t
10 Aug 23
Current report (foreign)
4:18pm
6-K
EX-99.1
zss44t
19 Jul 23
Current report (foreign)
9:08am
424B5
kyu hd498wia
18 Jul 23
Prospectus supplement for primary offering
11:59am
6-K
EX-10.1
qduwz9c6 toun
18 Jul 23
Current report (foreign)
11:57am
6-K
EX-99.1
xfm kfk15w74fcmit
14 Jul 23
PainReform Announces Pricing of $1.5 Million Concurrent Registered Direct
3:45pm
424B5
2irxbcnxos9nohm
14 Jul 23
Prospectus supplement for primary offering
12:26pm
6-K
EX-10.1
9k95y
14 Jul 23
Current report (foreign)
12:17pm
6-K
EX-99.1
m7ibhbiuo1d 7csm89
12 Jul 23
PainReform Announces Pricing of $2.7 Million Concurrent Registered Direct Offering and Private Placement
9:23am
6-K
EX-99.1
rgt 00k0i
7 Jun 23
PainReform Provides Regulatory Update on Second Part of its Phase 3 Clinical Trial of
4:33pm
6-K
EX-99.1
oewrgt
18 May 23
PainReform Announces Positive Pharmacokinetic (PK) Data in First Part of Phase 3
9:10am
6-K
EX-99.3
mbf2ds
15 May 23
Condensed Financial Statements
4:51pm